126 related articles for article (PubMed ID: 30011405)
1. Metabolic Alterations in Patients with Pheochromocytoma.
Erlic Z; Beuschlein F
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):129-136. PubMed ID: 30011405
[TBL] [Abstract][Full Text] [Related]
2. Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review.
Yang Y; Zhou T; Zhao X; Cai Y; Xu Y; Gang X; Wang G
Medicine (Baltimore); 2024 Apr; 103(17):e37916. PubMed ID: 38669419
[TBL] [Abstract][Full Text] [Related]
3. 15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma.
Mannelli M; Rapizzi E; Fucci R; Canu L; Ercolino T; Luconi M; Young WF
Endocr Relat Cancer; 2015 Aug; 22(4):T83-90. PubMed ID: 26113605
[TBL] [Abstract][Full Text] [Related]
4. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
5. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.
Crona J; Taïeb D; Pacak K
Endocr Rev; 2017 Dec; 38(6):489-515. PubMed ID: 28938417
[TBL] [Abstract][Full Text] [Related]
6. Energy and metabolic alterations in predisposition to pheochromocytomas and paragangliomas: the so-called Warburg (and more) effect, 15 years on.
Neumann HP; de Herder W
Endocr Relat Cancer; 2015 Aug; 22(4):E5-7. PubMed ID: 26273100
[No Abstract] [Full Text] [Related]
7. Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma.
Bliziotis NG; Kluijtmans LAJ; Soto S; Tinnevelt GH; Langton K; Robledo M; Pamporaki C; Engelke UFH; Erlic Z; Engel J; Deutschbein T; Nölting S; Prejbisz A; Richter S; Prehn C; Adamski J; Januszewicz A; Reincke M; Fassnacht M; Eisenhofer G; Beuschlein F; Kroiss M; Wevers RA; Jansen JJ; Deinum J; Timmers HJLM
Endocrine; 2022 Jan; 75(1):254-265. PubMed ID: 34536194
[TBL] [Abstract][Full Text] [Related]
8. Brown adipose tissue in patients with phaeochromocytoma.
Lean ME; James WP; Jennings G; Trayhurn P
Int J Obes; 1986; 10(3):219-27. PubMed ID: 3019909
[TBL] [Abstract][Full Text] [Related]
9. [Case of hormonally inactive pheochromocytoma developing in the adrenal gland].
Funyu T; Shiraiwa Y; Tateyama M
Horumon To Rinsho; 1968 May; 16(5):397-401. PubMed ID: 5749428
[No Abstract] [Full Text] [Related]
10. Mechanism for desensitization of beta-adrenergic receptor-stimulated lipolysis in adipocytes from rats harboring pheochromocytoma.
Prokocimer PG; Maze M; Vickery RG; Hoffman BB
Endocrinology; 1988 Jul; 123(1):528-33. PubMed ID: 2838264
[TBL] [Abstract][Full Text] [Related]
11. White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma.
Frontini A; Vitali A; Perugini J; Murano I; Romiti C; Ricquier D; Guerrieri M; Cinti S
Biochim Biophys Acta; 2013 May; 1831(5):950-9. PubMed ID: 23454374
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas.
Lu Y; Li P; Gan W; Zhao X; Shen S; Feng W; Xu Q; Bi Y; Guo H; Zhu D
Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):372-9. PubMed ID: 27219882
[TBL] [Abstract][Full Text] [Related]
13. Nationwide review of hormonally active adrenal tumors highlights high morbidity in pheochromocytoma.
Parikh PP; Rubio GA; Farra JC; Lew JI
J Surg Res; 2017 Jul; 215():204-210. PubMed ID: 28688648
[TBL] [Abstract][Full Text] [Related]
14. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care.
Eisenhofer G; Schott M; Bornstein S
Horm Metab Res; 2012 May; 44(5):325-7. PubMed ID: 22566193
[No Abstract] [Full Text] [Related]
16. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
[TBL] [Abstract][Full Text] [Related]
17. Changes in energy metabolism in pheochromocytoma.
Petrák O; Haluzíková D; Kaválková P; Štrauch B; Rosa J; Holaj R; Brabcová Vránková A; Michalsky D; Haluzík M; Zelinka T; Widimsky J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1651-8. PubMed ID: 23436923
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma of the adrenal gland selectively secreting dopamine -- a case report.
Belowska-Bień K; Kucharski W; Janczak D; Urban J
Endokrynol Pol; 2012; 63(5):391-7. PubMed ID: 23115074
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma: When to search a germline defect?
Buffet A; Burnichon N; Amar L; Gimenez-Roqueplo AP
Presse Med; 2018; 47(7-8 Pt 2):e109-e118. PubMed ID: 30100270
[TBL] [Abstract][Full Text] [Related]
20. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Timmers HJ; Hadi M; Carrasquillo JA; Chen CC; Martiniova L; Whatley M; Ling A; Eisenhofer G; Adams KT; Pacak K
J Nucl Med; 2007 Oct; 48(10):1599-606. PubMed ID: 17873132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
